Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 2
2002 1
2003 6
2004 4
2005 7
2006 6
2007 8
2008 15
2009 9
2010 8
2011 5
2012 6
2013 7
2014 6
2015 6
2016 4
2017 5
2018 4
2019 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 16357513

96 results

Results by year

Filters applied: . Clear all
Page 1
PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Rudin M, McSheehy PM, Allegrini PR, Rausch M, Baumann D, Becquet M, Brecht K, Brueggen J, Ferretti S, Schaeffer F, Schnell C, Wood J. Rudin M, et al. NMR Biomed. 2005 Aug;18(5):308-21. doi: 10.1002/nbm.961. NMR Biomed. 2005. PMID: 15918178
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow.
Stevenson JP, Rosen M, Sun W, Gallagher M, Haller DG, Vaughn D, Giantonio B, Zimmer R, Petros WP, Stratford M, Chaplin D, Young SL, Schnall M, O'Dwyer PJ. Stevenson JP, et al. J Clin Oncol. 2003 Dec 1;21(23):4428-38. doi: 10.1200/JCO.2003.12.986. J Clin Oncol. 2003. PMID: 14645433 Clinical Trial.
96 results